fundvisualizer.com

Carillon ClariVest Intl Stock AEISAX

Performance (before sales charge)

As of 02/29/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2023
Stock
0.38%
Non-U.S. Stock
96.52%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.87%
Other
2.22%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2023

Basic materials

3.43%

Consumer cyclical

13.69%

Financial services

15.62%

Real estate

0.22%

Consumer defensive

4.70%

Health care

9.05%

Utilities

3.21%

Communication services

4.79%

Energy

3.22%

Industrials

17.00%

Technology

16.71%

Top 10 holdings

As of 12/31/2023

iShares MSCI India ETF
3.36%
Novo Nordisk A/S Class B
3.10%
3i Group Ord
2.22%
Hyundai Motor Co
1.97%
ASML Holding NV
1.91%
Taiwan Semiconductor Manufacturing Co Ltd ADR
1.72%
Fairfax Financial Holdings Ltd Shs Subord.Vtg
1.61%
AstraZeneca PLC
1.59%
ITOCHU Corp
1.55%
Mitsubishi Corp
1.48%
Fund assets

$388.24 Million

Share class

A

Morningstar category

Foreign Large Value

Expense ratio

1.26%

Investment objective

Foreign Stock

Documents